Hydroxychloroquine and everolimus might stop breast cancer from coming back! A new Nature Medicine study from Drs. Angela DeMichele and Lewis A. Chodosh at the University of Pennsylvania found that everolimus and hydroxychloroquine—two medicines already approved for other conditions—can dramatically reduce the dormant tumor cells that often cause recurrence. In this small clinical trial, the combination of both drugs led to an 87% drop in dormant tumor cells and 100% recurrence-free survival at

Lancet’s Fake Data: Hydroxychloroquine Controversy Explained A fake dataset published in The Lancet fueled global bans on hydroxychloroquine—the first major early treatment for COVID-19. Despite being debunked, the study stayed online long enough to halt potentially life-saving care. Dr. McCullough exposes how scientific fraud, censorship, and retractions reshaped the pandemic narrative. 👉 Support truth in medicine and help restore integrity to research: mcculloughfnd.org 🎧 Credit: Freedude Po